ATG4B and diabetic kidney disease: The level of p-ATG4B protein in the DKD group was significantly lower than that in the Con group, and the expression of p-ATG4B in the aucubin-treated groups was significantly higher than that in the DKD group, whereas there was no statistical difference in the expression of ATG4B protein in the kidney tissues of the five groups.